Antidepressant activity of some Hypericum reflexum L. fil. extracts in the forced swimming test in mice

Journal of Ethnopharmacology

Volumn 112, Issue 1, 2007, Pages 115-121

  Sanchez Mateo C C ^a   Bonkanka, C X ^a   Prado, B ^a   Rabanal, R M ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Antidepressant; Behavioural effect; Forced swimming test; Hypericum reflexum L. fil.; Tetrabenazine test

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; BUTANOL; CHLOROFORM; HYPERICUM EXTRACT; HYPERICUM REFLEXUM EXTRACT; METHANOL EXTRACTION RESIDUE; PHENOBARBITAL; TETRABENAZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG POTENTIATION; FORCED SWIMMING TEST; HYPOTHERMIA; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PTOSIS; SLEEP TIME;

5-HYDROXYTRYPTOPHAN; ANIMALS; ANTIDEPRESSIVE AGENTS; BLEPHAROPTOSIS; BODY TEMPERATURE; CHEMICAL FRACTIONATION; FEMALE; HYPERICUM; HYPNOTICS AND SEDATIVES; MALE; MICE; MOTOR ACTIVITY; PENTOBARBITAL; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SLEEP;

ANIMALIA; HYPERICUM REFLEXUM; MUS;

EID: 34247868695     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.02.019     Document Type: Article

References (47)

1. Apaydin S., Zeybek U., Ince I., Elgin G., Karamenderes C., Ozturk B., and Tuglular I. Hypericum triquetrifolium Turra. extract exhibits antinociceptive activity in the mouse. Journal of Ethnopharmacology 67 (1999) 307-312
2. Barnes J., Anderson L.A., and Phillipson J.D. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology 53 (2001) 583-600
3. Bhattacharya S.K., Chakrabarti A., and Chatterjee S.S. Activity profiles of two hyperforin-containing Hypericum extracts in behavioural models. Pharmacopsychiatry 31 (1998) 22-29
4. Biffignandi P.M., and Bilia A.N. The growing knowledge of St. John's Wort (Hypericum perforatum L.) drug interactions and their clinical significance. Current Therapeutic Research 61 (2000) 389-394
5. Bombardelli E., and Morazzoni P. Hypericum perforatum. Fitoterapia 66 (1995) 43-68
6. Bourin M. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?. Fundamental and Clinical Pharmacology 4 (1990) 49-64
7. Butterweck V., Wall A., Liefländer-Wulf U., Winterhoff H., and Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30 (1997) 117-124
8. Butterweck V., Petereit F., Winterhoff H., and Nahrsted A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Medica 64 (1998) 291-294
9. Butterweck V., Jürgenliemk G., Nahrstedt A., and Winterhoff H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Medica 66 (2000) 3-6
10. Butterweck V. Mechanism of action of St John's wort in depression. What is known?. CNS Drugs 17 (2003) 539-562
11. Butterweck V., Christoffel V., Nahrstedt A., Petereit F., Spengler B., and Winterhoff H. Step by step removal of hyperforin and hypericin: activity profile of different Hypercium preparations in behavioural models. Life Sciences 73 (2003) 627-639
12. Butterweck V., Liefländer-Wulf U., Winterhoff H., and Nahrstedt A. Plasma levels of hypericin in presence of procyaniadin B2 and hyperoside: a pharmacokinetic study in rats. Planta Medica 69 (2003) 189-192
13. Chatterjee S.S., Nöldner M., Koch E., and Erdelmeier C. Antidepressant activity of Hypericum perforatum and Hyperforin: the neglected possibility. Pharmacopsychiatry 31 (1998) 7-15
14. Corne S.J., Pickering R.W., and Warner B.T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. British Journal of Pharmacology 20 (1963) 106-120
15. Daudt R., von Poser G.L., Neves G., and Rates S.M.K. Screening for the antidepressant activity of some species of Hypericum from South Brazil. Phytotherapy Research 14 (2000) 344-346
16. Darias V., Bravo L., Barquín E., Martín-Herrera D., and Fraile C. Contribution to the ethnopharmacological study of the Canary Islands. Journal of Ethnopharmacology 15 (1986) 169-193
17. Darias V., Bravo L., Rabanal R., Sánchez Mateo C., González Luis R.M., and Hernández Pérez A.M. New contribution to the ethnopharmacological study of the Canary Islands. Journal of Ethnopharmacology 25 (1989) 77-92
18. Di Carlo G., Borrelli F., Ernst E., and Izzo A.A. St John's wort: Prozac from the plant kingdom. Trends in Pharmacological Sciences 22 (2001) 292-297
19. Gnerre C., von Poser G.L., Ferraz A., Viana A., Testa B., and Rates S.M.K. Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil. Journal of Pharmacy and Pharmacology 53 (2001) 1273-1279
20. Greeson J.M., Sanford B., and Monti D.A. St John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153 (2001) 402-414
21. Herrera R.M., Pérez M., Martín-Herrera D.A., López-García, and Rabanal R.M. Antimicrobial activity of extracts from plants endemic to the Canary Islands. Phytotherapy Research 10 (1996) 364-366
22. Izzo A.A., and Ernst E. Interactions between herbal medicines and prescribed drugs. A systematic review. Drugs 61 (2001) 2163-2175
23. Knüppel L., and Linde K. Adverse effects of St John's Wort: a systematic review. The Journal of Clinical Psychiatry 65 (2004) 1470-1479
24. Linde K., Ramírez G., Mulrow C.D., Pauls M., Weidenhammer W., and Melchart D. St. John's Wort for depression-an overview and metaanalysis of randomised clinical trials. British Medicinal Journal 313 (1996) 253-258
25. Mannel M. Drug interaction with St. John's Wort. Mechanisms and clinical implications. Drug Safety 27 (2004) 773-797
26. Mennini T., and Gobbi M. The antidepressant mechanism of Hypericum perforatum. Life Sciences 75 (2004) 1021-1027
27. Mukherjee P.K., Suresh B., and Verpoorte R. CNS active potentials of some Hypericum species of India. Phytomedicine 8 (2001) 331-337
28. Müller W.E. Current St. John's wort research from mode of action to clinical efficacy. Pharmacological Research 47 (2003) 101-109
29. Nöldner M., and Schötz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Medica 68 (2002) 577-580
30. Öztürk Y., Aydin S., Beis R., and Hüsnü Can Baser K. Effects of Hypericum calycinum L. extract on the central nervous system in mice. Phytotherapy Research 10 (1996) 700-702
31. Pérez de Paz P.L., and Hernández-Padrón C.E. In: Francisco Lemus (Ed). Plantas medicinales o útiles en la flora canaria. Aplicaciones populares (1999), La Laguna, Spain 115
32. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arhives Internationales de Pharmacodynamie et Therapie 229 (1977) 327-336
33. Prado B., Rabanal R.M., and Sánchez-Mateo C.C. Evaluation of the central properties of several Hypericum species from the Canary Islands. Phytotherapy Research 16 (2002) 740-744
34. Rabanal R.M., Arias A., Prado B., Hernández-Pérez M., and Sánchez-Mateo C.C. Antimicrobial studies on three species of Hypericum from the Canary Islands. Journal of Ethnopharmacology 81 (2002) 287-292
35. Rabanal R.M., Bonkanka C.X., Hernánez-Pérez M., and Sánchez-Mateo C.C. Analgesic and topical anti-inflammatory activity of Hypericum canariense L. and Hypericum glandulosum Ait. Journal of Ethnopharmacology 96 (2005) 591-596
36. Rieli Mendes F., Mattei R., and Luiz de Araujo Carlini E. Activity of Hypericum brasiliense and Hypericum cordatum on the central nervous system in rodents. Fitoterapia 73 (2002) 462-471
37. Rodríguez-Landa J.F., and Contreras C.M. A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine 10 (2003) 688-699
38. Roz N., Mazur Y., Hirshfeld A., and Rehavi M. Inhibition of vesicular uptake of monoamines by hyperforin. Life Sciences 71 (2002) 2227-2237
39. Sánchez-Mateo C.C., Prado B., and Rabanal R.M. Antidepressant effects of the methanol extract of several Hypericum species from the Canary Islands. Journal of Ethnopharmacology 79 (2002) 119-127
40. Sánchez-Mateo C.C., Darias V., Expósito-Orta M.A., and Albertos L.M. Neuropharmacological study of hetero[2,1]benzothiazepine derivatives analogues of tianeptine. Il Farmaco 58 (2003) 1-10
41. Sánchez-Mateo C.C., Bonkanka C.X., Prado B., and Rabanal R.M. Antidepressant properties of some Hypericum canariense L. and Hypericum glandulosum Ait. extracts in the forced swimming test in mice. Journal of Ethnopharmacology 96 (2005) 591-596
42. Sánchez-Mateo C.C., Bonkanka C.X., Hernández-Pérez M., and Rabanal R.M. Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. fil. Journal of Ethnopharmacology 107 (2006) 1-6
43. Schulz V. Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. Phytomedicine 8 (2001) 152-160
44. Schulz V. Clinical trials with Hypericum extracts in patients with depression-results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine 9 (2002) 468-474
45. Shank R.P., Gardocki J.F., Shcneider C.R., Vaught J.L., Settler P.E., Maryanoff B.E., and McComsey D.F. Preclinical evaluation of McN-5707 as a potential antidepressant. Journal of Pharmacology and Experimental Therapeutics 242 (1987) 74-84
46. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. second ed. (1987), Springer-Verlag, New York pp. 110-134
47. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409